Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2009, Vol. 3 Issue (4) : 452-458     DOI: 10.1007/s11684-009-0080-z
Research articles |
Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive use
Qiong DAI MD,Bei LIU MD,Yukai DU MM,
Department of Maternal and Children Health Care and Adolescent Hygiene, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;
Download: PDF(175 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  The authors performed a meta-analysis of case-control studies that addressed whether reproductive factors and oral contraceptive use were associated with breast cancer by searching the MEDLINE, PubMed, Proquest, Embase, ScienceDirect, African Healthline, BMJ Health Intelligence and Chinese Periodical net databases for all English-language and Chinese-language papers published from January 1, 1997 to December 31, 2007. A total of 15 studies calculating pool ORs indicated that menopausal age >50yr [odds ratio (OR), 1.39; 95% confidence interval (CI), 1.22―1.57] and oral contraceptive use (OR, 2.12*, “*”: summary OR was adjusted; 95% CI, 1.24―3.62) were correlated with the increase in breast cancer risk while the summary OR based on number of full-term pregnancies ≥1 (OR, 0.63*; 95% CI, 0.60―0.68) and breast-feeding (OR, 0.76; 95% CI, 0.64―0.90) indicated no association with breast cancer risk. The correlation was statistically significant. Menopausal age >50yr and oral contraceptive use are positively correlated with an increase in breast cancer risk while breast-feeding and number of full-term pregnancies ≥1 are protective factors.
Keywords meta-analysis      breast cancer      risk factors      reproductive factors      oral contraceptive use      
Issue Date: 05 December 2009
URL:  
http://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0080-z     OR     http://academic.hep.com.cn/fmd/EN/Y2009/V3/I4/452

doi: 10.1023/A:1014896417653
Li C I, Stanford J L, Daling J R. Anthropometric variables in relation to risk of breastcancer in middle-aged women. Int J Epidemiol, 2000, 29(2): 208―213

doi: 10.1093/ije/29.2.208
Sala E, Warren R, McCann J, Duffy S, Luben R, Day N. Highrisk mammographic parenchymal patterns, hormone replacement therapyand other risk factors: a cases-control study. Int J Epidemiol, 2000, 29(4): 629―636

doi: 10.1093/ije/29.4.629
Moorman P G, Kuwabara H, Millikan R C, Newman B. Menopausalhormones and breast cancer in a biracial population. Am J Public Health, 2000, 90(6): 966―971

doi: 10.2105/AJPH.90.6.966
Gomes A L, Guimarães M D, Gomes C C, Chaves I G, Gobbi H, Camargos A F. Risk factors for breast cancer among pre- or post-menopausalwomen in Belo Horizonte, Brazil. GynecolObstet Invest, 2001, 52(3): 173―179

doi: 10.1159/000052968
Petro-Nustas W, Norton M E, al-Masarweh I. Risk factors for breast cancer in Jordanian women. J Nurs Scholarsh, 2002, 34(1): 19―25

doi: 10.1111/j.1547-5069.2002.00019.x
McCormack V A, Mangtani P, Bhakta D, McMichael A J, dos Santos Silva I. Heterogeneityof breast cancer risk within the South Asian female population inEngland: a population-based case-control study of first-generationmigrants. Br J Cancer, 2004, 90(1): 160―166

doi: 10.1038/sj.bjc.6601440
Zhang Y, Wise J P, Holford T R, Xie H, Boyle P, Zahm S H, Rusiecki J, Zou K, Zhang B, Zhu Y, Owens P H, Zheng T. Serum polychlorinated biphenyls,cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticutwomen. Am J Epidemiol, 2004, 160(12): 1177―1183
Lee M M, Chang I Y, Horng C F, Chang J S, Cheng S H, Huang A. Breastcancer and dietary factors in Taiwanese women. Cancer Causes Control, 2005, 16(8): 929―937

doi: 10.1007/s10552-005-4932-9
Thanos J, Cotterchio M, Boucher B A, Kreiger N, Thompson L U. Adolescent dietary phytoestrogenintake and breast cancer risk (Canada). Cancer Causes Control, 2006, 17(10): 1253―1261

doi: 10.1007/s10552-006-0062-2
Freedman L S, Potischman N, Kipnis V, Midthune D, Schatzkin A, Thompson F E, Troiano R P, Prentice R, Patterson R, Carroll R, Subar A F. A comparison of two dietaryinstruments for evaluating the fat-breast cancer relationship. Int J Epidemiol, 2006, 35(4): 1011―1021

doi: 10.1093/ije/dyl085
Rosner B, Colditz G A, Willett W C. Reproductive risk factor in a prospective study of breastcancer: the Nurses’ Health Study. Am J Epidemiol, 1994, 139: 819―835
Trichopoulos D, Hsieh C C, MacMahon B, Lin T M, Lowe C R, Mirra A P, Ravnihar B, Salber E J, Valaoras V G, Yuasa S. Age at any birth and breastcancer risk. Int J Cancer, 1983, 31(6): 701―704

doi: 10.1002/ijc.2910310604
Han D F, Ma J, Zhou X, Qiu H, Fang L, Huang S. ACase-control study on the risk of female beast cancer in Wuhan area. Zhonghua Liu Xing Bing Xue Za Zhi, 2004, 25(3): 256―260 (in Chinese)
Harris J R, Lippman M E. Diseases of the breast. 3rd ed. Lippmcott Williamand Wilkins, Inc., U S A, 2006, 214
Collaborative Group on Hormonal Factors inBreast Cancer. Breast cancer and breastfeeding:collaborative reanalysis of individual data from 47 epidemiologicalstudies in 30 countries, including 50302 women with breast cancerand 96973 women without the disease. Lancet, 2002, 360(9328): 187―195

doi: 10.1016/S0140-6736(02)09454-0
Tryggvadóttir L, Tulinius H, Eyfjord J E, Sigurvinsson T. Breastfeedingand reduced risk of breast cancer in an Icelandic cohort study. Am J Epidemiol, 2001, 154(1): 37―42

doi: 10.1093/aje/154.1.37
Jernström H, Lubinski J, Lynch H T, Ghadirian P, Neuhausen S, Isaacs C, Weber B L, Horsman D, Rosen B, Foulkes W D, Friedman E, Gershoni-Baruch R, Ainsworth P, Daly M, Garber J, Olsson H, Sun P, Narod S A. Breast-feedingand the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst, 2004, 96(14): 1094―1098
Li H L. Repoductive factor and breast cancer in a population-based case-controlstudy. Zhongliu (Shanghai), 2000, 20(2): 88―91 (in Chinese)
Kahlenborn C, Modugno F, Potter D M, Severs W B. Oral contraceptive use as a risk factor for premenopausal breastcancer: a meta-analysis. Mayo Clin Proc, 2006, 81(10): 1290―1302

doi: 10.4065/81.10.1290
Thomas D B. Oral contraceptive breast cancer: review of the epidemiologic literature. Contraception, 1991, 43(6): 597―642

doi: 10.1016/0010-7824(91)90006-2
Hu J. MedicalResearch Methodology. Chengdu: Sichuan Science and Technology Press, 2007, 120
[1] Xinsen Xu,Kai Qu,Qing Pang,Zhixin Wang,Yanyan Zhou,Chang Liu. Association between telomere length and survival in cancer patients: a meta-analysis and review of literature[J]. Front. Med., 2016, 10(2): 191-203.
[2] Alexandra Urman,H. Dean Hosgood. Curbing the burden of lung cancer[J]. Front. Med., 2016, 10(2): 228-232.
[3] Lan Wang,Jueheng Wu,Jie Yuan,Xun Zhu,Hongmei Wu,Mengfeng Li. Midline2 is overexpressed and a prognostic indicator in human breast cancer and promotes breast cancer cell proliferation in vitro and in vivo[J]. Front. Med., 2016, 10(1): 41-51.
[4] Aixiu Qiao,Feng Gu,Xiaojing Guo,Xinmin Zhang,Li Fu. Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications[J]. Front. Med., 2016, 10(1): 33-40.
[5] Jiangang Pan,Mo Liu,Xing Zhou. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with non-muscle invasive bladder cancer? An update and cumulative meta-analysis[J]. Front. Med., 2014, 8(2): 241-249.
[6] Xiangsong Wu, Maolan Li, Wenguang Wu, Jiasheng Mu, Lin Zhang, Qichen Ding, Qian Ding, Hao Weng, Runfa Bao, Yijun Shu, Ping Dong, Jun Gu, Jianhua Lu, Yingbin Liu. The role of prophylactic transpapillary pancreatic stenting in distal pancreatectomy: a meta-analysis[J]. Front Med, 2013, 7(4): 499-505.
[7] Xiangwei Li, Yu Yang, Jianmin Liu, Feng Zhou, Wei Cui, Ling Guan, Fei Shen, Cong Gao, Mufei Li, Qi Jin, Lei Gao. Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a meta-analysis[J]. Front Med, 2013, 7(3): 354-366.
[8] Zhiming Zhu, Peijian Wang, Shuangtao Ma. Metabolic hypertension: concept and practice[J]. Front Med, 2013, 7(2): 201-206.
[9] Renling Pei, Ye Xu, Yan Wei, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin, Yuntao Xie. Association of SIPA1 545 C>T polymorphism with survival in Chinese women with metastatic breast cancer[J]. Front Med, 2013, 7(1): 138-142.
[10] Jin Gao, Ben Panizza, Newell W. Johnson, Scott Coman, Alan R. Clough. Basic consideration of research strategies for head and neck cancer[J]. Front Med, 2012, 6(4): 339-353.
[11] Zhiping Yang, Qiong Wu, Kaichun Wu, Daiming Fan. Scientific publications on systematic review and meta-analysis from Chinese authors: a 10-year survey of the English literature[J]. Front Med, 2012, 6(1): 94-99.
[12] Suchinda Malaivijitnond. Medical applications of phytoestrogens from the Thai herb Pueraria mirifica[J]. Front Med, 2012, 6(1): 8-21.
[13] Marie-Germaine Bousser. Stroke prevention: an update[J]. Front Med, 2012, 6(1): 22-34.
[14] Ling XU. How to judge the association of postmenopausal hormone therapy and the risk of breast cancer[J]. Front Med Chin, 2010, 4(3): 290-293.
[15] Jun-Jie XIAO MD, Yi-Han CHEN MD, PhD, . Prevalence of cardiovascular diseases in China[J]. Front. Med., 2010, 4(1): 16-20.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed